Sonoma Pharmaceuticals, Inc. Forecast, price target & analysts
Sonoma Pharmaceuticals, Inc. Target price 2024 - Analyst rating & recommendation
Sonoma Pharmaceuticals, Inc. Classifications & Recommendation:
Sonoma Pharmaceuticals, Inc. Price Target
| Target Price | $17.00 |
| Price | $2.56 |
| Potential |
564.04%
register free of charge
|
| Number of Estimates | 1 |
|
1 Analyst has issued a Sonoma Pharmaceuticals, Inc. price target 2025.
The average Sonoma Pharmaceuticals, Inc. target price is $17.00.
This is
564.04%
register free of charge
|
|
| A rating was issued by 1 analysts: 1 Analysts recommend Sonoma Pharmaceuticals, Inc. to buy, 0 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Sonoma Pharmaceuticals, Inc. stock has an average upside potential 2025 of
564.04%
register free of charge
|
Sales and Margin forecast 2025, 2026 & 2027
| Mar '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Million $ | 12.74 | 15.47 |
| 3.99% | 21.42% |
1 Analyst has issued a sales forecast Sonoma Pharmaceuticals, Inc. 2025 . The average Sonoma Pharmaceuticals, Inc. sales estimate is
This results in the following potential growth metrics:
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 & 2027
| Mar '24 |
2025 Estimates |
|
|---|---|---|
| EV/Sales | negative |
Based on analysts' sales estimates for 2025, the Sonoma Pharmaceuticals, Inc. stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of
This results in the following potential growth metrics and future valuations:
Sonoma Pharmaceuticals, Inc....
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
